Urology

Boston Scientific, Coloplast Lead European Erectile Dysfunction Device Market Driven by Three-Piece Implant Popularity

Growth in the erectile dysfunction treatment market is tied to the overwhelming popularity of inflatable devices; the market also includes malleable erectile dysfunction devices.

Read More

Coloplast, Wellspect HealthCare Lead Europe Urology Device Market through Profitable Urinary Catheters

The European market for urological devices is expected to expand steadily to reach just under €2 billion by 2022; growth in procedure numbers for each treatment type is expected to be positive.

Read More

Boston Scientific, C.R. Bard, Coloplast Lead Commoditized Billion Dollar US Urological Device Market

The overall urology market is expected to reach nearly $3 billion by 2022; the market includes devices for urinary incontinence, stone management, BPH treatment devices, urological endoscopes, prostate cancer, nephrostomy, erectile dysfunction and urodynamic equipment.

Read More

Precise Heat Laser Ablation Becomes an Increasingly Viable Treatment for Prostate Cancer

Capturing an image of a prostate cancer has been difficult because prostate tissue and tumor tissue are so similar. Precise, non-invasive surgical treatment has proved difficult as a result. Now researchers report that prostate cancer patients may soon have a new option to treat their disease: laser heat.

Read More

Boston Scientific, Olympus Lead U.S. BPH Market Driven by Prevalent Laser and Transurethral Resection Prostate Procedures

The total BPH treatment device market is valued at over $152 million; the growth of mobile services for minimally invasive BPH treatments reduces the need for capital equipment purchases.

Read More

Gothenburg PSA Study Shows Impact of Screening Cessation

The Gothenburg study involved men 50 to 64 years at baseline; 9950 men were randomized to an organized 2-year PSA screening program, and 9949, who were not invited to formal screening but could have been screened on their own, served as the control group.

Read More

Survey Shows Penile Implants to Treat Erectile Dysfunction Have High User Satisfaction Rating

For men with severe erectile dysfunction (ED), the radical option of a penile implant may very well be worth the high sticker price, according to a study published in the Journal of Sexual Medicine.

Read More

Innovative Surgical Technique to Minimize Damage During Urology Cancer Procedure

Dr. Bradley Bell uses a minimally invasive technique to treat kidney cancer via high-tech da Vinci Surgical System equipment for robotic surgery. He uses the equipment with a surgical technique that lets him minimize damage to the kidney because he doesn’t have to cut off the blood supply.

Read More

Affordable Care Act Effect On Urology Procedures And Reimbursement

A political, economic, social, and technological (PEST) analysis of the U.S. urology device market with a focus on the possible impacts that policy changes can have on Medicare and Medicaid Reimbursements, procedure volumes, sales volumes, and market values of medical devices.

Read More

Boston Scientific Acquires $1.6 Billion AMS Urology Portfolio from Endo Health Solutions

Boston Scientific finalized their $1.6 billion acquisition of the American Medical Systems (AMS) urology portfolio previously owned by Endo Health Solutions. Plus a $50 million bonus will be paid out if certain market milestones are achieved in 2016.

Read More